The vascular closure devices market size was valued at USD 1.78 billion in 2024 and is expected to reach USD 3.25 billion by 2032, growing at a CAGR of 7.85% over 2025-2032.
A robust global vascular closure devices market is on its way, partly due to the increased prevalence of interventional and diagnostic cardiovascular procedures. Considering that there are more than 1,500 PCI-treated individuals per million people in countries such as Germany (ESC Atlas), there is an increasing requirement for fast and effective hemostasis following the procedure. This increase is further accentuated by the escalating burden of cardiovascular disease, still the number one propelling factor of the world’s population, being responsible for 17.9 million deaths each year (WHO). Adoption has been accelerated in the U.S. market for vascular closure devices due to favorable reimbursement policies, such as those under Medicare Advantage, and growing procedural volumes.
For instance, Vivasure Medical achieved a key milestone with more than 100 patients now treated with the PerQseal system, highlighting performance and clinical safety.
The R&D activities, including the PATCH IDE study on the PerQseal vascular closure device of the company, together support the growth of the vascular closure devices market, at the technological forefront and with enhanced clinical outcomes. Elevated number of regulatory approvals, including FDA approval for Cordis’ Mynx Control Venous device and the CE mark for PerQseal Elite, highlight a favorable regulatory scenario. On the other hand, companies specializing in vascular closure devices, including Haemonetics, Vasorum, and Vivasure, are receiving significant investments, USD 34.35 million from Haemonetics for the development of the PerQseal, and they have recently introduced to the market the Vascade MVP XL. Such trends will favor the vascular closure devices market size, expanding vascular closure devices market share, particularly in developed regions.
For instance, Vascade MVP XL was introduced in a limited U.S. release by Haemonetics Corporation, and it speaks to growing comfort and growth prospects in the vascular closure devices market. Both these developments underscore the continued development and investment within the global vascular closure devices market and illustrate future demand going forward in line with advancing vascular closure devices market trends.
Market Dynamics:
Drivers:
Advancing Interventional Techniques and Favorable Regulatory Backing Fueling Demand
The vascular closure devices market is growing, owing to the growing preference for interventional cardiology and radiology procedures with minimal incisions, which require prompt and safe hemostasis after the procedure. Globally, more than 2,000,000 cardiac catheterizations are performed each year, and as the trend continues toward increasing numbers of outpatient-based interventions, the demand for effective closure systems has grown. With expedited approvals from the U.S. FDA of devices, such as Medtronic’s FemoSeal and Abbott’s ProGlide systems, the regulatory environment works to facilitate innovation. Furthermore, healthcare facilities are spending heavily on infrastructure to support same-day discharge processes, which is driving product demand.
The technological innovations, such as bioabsorbable closure devices, extravascular closure devices that are coming through, are also influencing the quick adoption supported by the rise in R&D investments, especially by players such as Cardinal Health and Terumo, and growing clinical data supporting device safety.
For instance, fewer vascular complications and early walking times with manual compression are further fostering physician confidence. Increasing need for improved procedural efficiency and patient comfort is expected to drive the vascular closure devices market, and rising collaboration between device manufacturers and hospitals provides them with better supply chain integration.
Restraints:
High Costs and Procedure-Specific Limitations Hampering Wider Adoption
Advanced closure devices, including suture-mediated devices, are often more expensive than manual compression by far (prices range USD 150–300 per unit) and place a significant economic burden on the smaller-sized health care facility that has low procedural volume. In addition, anatomic limitations, such as small and calcium femoral arteries, in some cases, prohibit the utilization of certain devices and result in procedural failure or complications. Reimbursement discrepancies in developing countries subsequently restrict the market growth, where cost-effectiveness is still a major focus. As per JACC, there could be elevated complications with closure devices for peripheral procedures compared to standard compression, especially in those with peripheral artery disease.
Furthermore, supply-chain uncertainty and device recalls, including the 2022 voluntary recall of a primary closure system because of a deployment failure, affect price stability and physician confidence. There is a lack of knowledge among interventionalists in resource-poor settings, acting as a practical barrier to its uptake. These constraints are projected to hinder the otherwise rising demand for vascular closure devices, particularly in price-sensitive healthcare settings.
By Product
Among the types, the active approximators held the largest share in the global vascular closure devices market in 2024, contributing 65.7% of the market. These devices, which utilize clip- and suture-based mechanisms, are extensively preferred for their excellent hemostatic control and faster time of ambulation, particularly in the context of high-risk and complex interventions. Their favorable clinical results and higher surgeon preference have led to increasing hospital utilization. On the other hand, passive approximators, collagen plugs, and sealants held the highest CAGR over the forecast period as these are easy to use, require less operator experience, and growing usage of these in the outpatient and ambulatory settings justifies the focus on the procedural lab and operating room efficacies and safeties.
By Application
Cardiac Interventions dominated the application segment in 2024 due to the global burden of cardiovascular diseases and the growing incidence of percutaneous coronary interventions (PCIs) being performed annually. Increased closure device use to decrease the rates of post-procedure complications in large-volume cardiac catheterization procedures further perpetuates this dominance. The peripheral vascular interventions segment is projected to witness the second-highest growth, propelled by the increasing incidence of peripheral artery disease and growing adoption of endovascular procedures, which in turn requires the need for efficient vascular access site management.
By End Use
In 2024, hospitals & clinics retained the largest share of revenue due to greater procedural volumes and the established cardiac care infrastructure. Active closure devices are still the first preference for complex interventional procedures at these sites. Nevertheless, Ambulatory Surgical Centers (ASCs) are one of the fastest-growing segments of the market, driven by the trend in healthcare toward less invasive surgery, lower procedure costs, and faster patient turnover. The convenience and cost effectiveness of the operating room provided by ASCs make them well suited for elective vascular operations for which rapid return of function and ready discharge on the same day can be accomplished.
North America held the largest share of the vascular closure devices market in 2024, primarily due to the large number of cardiovascular procedures performed, well-established healthcare infrastructure, and favorable reimbursement scenario in the U.S. and Canada.
The U.S. vascular closure devices market size was valued at USD 0.52 billion in 2024 and is expected to reach USD 0.84 billion by 2032, growing at a CAGR of 6.19% over 2025-2032. The U.S. vascular closure devices market is poised to emerge as the leading regional industry with more than 1.5 million cardiac catheterizations performed per annum, rapid regulatory approvals, and adoption of new devices. The market is dominated by its country and supported by large R&D investments by major players, such as Abbott and Medtronic. Canada comes next, with a rising number of procedures and a move towards minimally invasive therapies. In Mexico, the phenomenon is better known, and health infrastructure is improving; however, it is still limited.
Europe is one of the leading regions in the global market for vascular closure devices, and in this region, Germany has the highest rate of percutaneous coronary intervention (PCI) procedures performed per million inhabitants, at more than 1,600 annually (ESC Atlas). The domination of Germany is due to strong cardiovascular care systems and early adoption of newer closure devices.
Eastern Europe, especially Poland and Turkey, is the fastest-growing region in Europe, owing to the growing number of investments in the healthcare infrastructure and the increasing burden of cardiovascular diseases. France and the U.K. are also large contributing countries with established markets, while Italy and Spain are developing quickly as a result of increasing procedural adoption and reimbursement.
Asia-Pacific is growing at a rapid rate on account of growing burdens of cardiovascular diseases, health expenditures, and procedure volumes in countries such as China and India. Large patient pool suffering from cardiovascular disorders, government funding to provide improved cardiovascular treatment, and increasing interventional cardiology procedure volume are some key factors responsible for the dominance of the Chinese regional market. India is second due to increasing patient awareness and improving investments in healthcare infrastructure.
Japan continues to be a mature market that experiences decent growth due to the aging population. The largest and fastest-growing markets in the region are India and the Southeast Asian states, where advanced vascular closure products are becoming more widely available, and outpatient procedures are rising.
Leading vascular closure devices companies in the market include Abbott, Medtronic, Terumo Medical Corporation, Cardinal Health, Teleflex Incorporated, Merit Medical Systems, Haemonetics Corporation, Boston Scientific Corporation, Vivasure Medical, and Vasorum Ltd.
In August 2024, Haemonetics announced the full market release of its VASCADE MVP XL mid-bore venous closure system in the U.S. The device features an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.
In July 2024, Cordis received FDA approval for its MYNX CONTROL VENOUS Vascular Closure Device, designed for procedures with access sites from 6F–12F. The device leverages GRIP TECHNOLOGY, based on hydrophilic, bioinert polyethylene glycol (PEG), and resorbs 3x faster than collagen-based sealants, providing the quickest time to hemostasis of any venous closure device on the market.
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 1.78 billion |
| Market Size by 2032 | USD 3.25 billion |
| CAGR | CAGR of 7.85% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Passive Approximators (Collagen Pugs, Sealant or Gel-based Devices, and Compression-assist Devices), Active Approximators (Suture-based Devices, Clip-based Devices, and External Homeostatic Devices)) • By Application (Cardiac Interventions, Cerebrovascular Interventions, Peripheral Vascular Interventions, and Others) • By End Use (Hospitals and Clinics, Ambulatory Surgical Centers, and Cardiac Catherization Laboratories) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Abbott, Medtronic, Terumo Medical Corporation, Cardinal Health, Teleflex Incorporated, Merit Medical Systems, Haemonetics Corporation, Boston Scientific Corporation, Vivasure Medical, and Vasorum Ltd. |
Ans: The Vascular Closure Devices Market is projected to grow at a CAGR of 7.85% during the forecast period.
Ans: By 2032, the Vascular Closure Devices Market is expected to reach USD 3.25 billion, up from USD 1.78 billion in 2024.
Ans: The vascular closure devices market is growing, owing to the growing preference for interventional cardiology & radiology procedures with minimal incisions, which require prompt and safe hemostasis after the procedure.
Ans: Advanced closure devices like suture-mediated devices are often more expensive than manual compression by far (prices range USD 150–300 per unit) and place a significant economic burden on the smaller-sized health care facility that has low procedural volume.
Ans: North America is the dominant region in the Vascular Closure Devices market.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of Cardiovascular and Interventional Procedures (2024)
5.2 Vascular Closure Device Utilization Trends by Procedure Type (2024)
5.3 Healthcare Expenditure on Interventional Cardiology (2024)
5.4 Adoption Trends in Ambulatory and Outpatient Settings (2024)
5.5 Regulatory and Reimbursement Landscape (2024)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Vascular Closure Devices Market Segmentation by Product
7.1 Chapter Overview
7.2 Passive Approximators
7.2.1 Passive Approximators Market Trends Analysis (2021-2032)
7.2.2 Passive Approximators Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.3 Collagen Pugs
7.2.3.1 Collagen Pugs Market Trends Analysis (2021-2032)
7.2.3.2 Collagen Pugs Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.4 Sealant or Gel-based Devices
7.2.4.1 Sealant or Gel-based Devices Market Trends Analysis (2021-2032)
7.2.4.2 Sealant or Gel-based Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.2.5 Compression-assist Devices
7.2.5.1 Compression-assist Devices Market Trends Analysis (2021-2032)
7.2.5.2 Compression-assist Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Active Approximators
7.3.1 Active Approximators Market Trends Analysis (2021-2032)
7.3.2 Active Approximators Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.3 Suture-based Devices
7.3.3.1 Suture-based Devices Market Trends Analysis (2021-2032)
7.3.3.2 Suture-based Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.4 Clip-based Devices
7.3.4.1 Clip-based Devices Market Trends Analysis (2021-2032)
7.3.4.2 Clip-based Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3.5 External Homeostatic Devices
7.3.5.1 External Homeostatic Devices Market Trends Analysis (2021-2032)
7.3.5.2 External Homeostatic Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Vascular Closure Devices Market Segmentation By Application
8.1 Chapter Overview
8.2 Cardiac Interventions
8.2.1 Cardiac Interventions Market Trend Analysis (2021-2032)
8.2.2 Cardiac Interventions Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Cerebrovascular Interventions
8.3.1 Cerebrovascular Interventions Market Trends Analysis (2021-2032)
8.3.2 Cerebrovascular Interventions Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Peripheral Vascular Interventions
8.4.1 Peripheral Vascular Interventions Market Trends Analysis (2021-2032)
8.4.2 Peripheral Vascular Interventions Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Others
8.5.1 Others Market Trends Analysis (2021-2032)
8.5.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Vascular Closure Devices Market Segmentation By End Use
9.1 Chapter Overview
9.2 Hospitals and Clinics
9.2.1 Hospitals and Clinics Market Trends Analysis (2021-2032)
9.2.2 Hospitals and Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Ambulatory Surgical Centers
9.3.1 Ambulatory Surgical Centers Market Trends Analysis (2021-2032)
9.3.2 Ambulatory Surgical Centers Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Cardiac Catherization Laboratories
9.4.1 Cardiac Catherization Laboratories Market Trends Analysis (2021-2032)
9.4.2 Cardiac Catherization Laboratories Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America Vascular Closure Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.2.3 North America Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.2.4 North America Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.2.5 North America Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.2.6.2 USA Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.2.6.3 USA Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.2.7.2 Canada Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.2.7.3 Canada Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.2.8.2 Mexico Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.2.8.3 Mexico Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3 Europe
10.3.1 Trends Analysis
10.3.2 Europe Vascular Closure Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.3.3 Europe Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.3.4 Europe Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.5 Europe Vascular Closure Devices Market Estimates and Forecasts, By End Use(2021-2032) (USD Billion)
10.3.6 Germany
10.3.1.6.1 Germany Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.3.1.6.2 Germany Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.1.6.3 Germany Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.7 France
10.3.7.1 France Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.3.7.2 France Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.7.3 France Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.8 UK
10.3.8.1 UK Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.3.8.2 UK Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.8.3 UK Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.9 Italy
10.3.9.1 Italy Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.3.9.2 Italy Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.9.3 Italy Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.10 Spain
10.3.10.1 Spain Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.3.10.2 Spain Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.10.3 Spain Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.12 Poland
10.3.12.1 Poland Vascular Closure Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.3.12.1 Poland Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.3.12.3 Poland Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.12.3 Poland Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.13 Turkey
10.3.13.1 Turkey Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.3.13.2 Turkey Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.13.3 Turkey Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.3.14 Rest of Europe
10.3.14.1 Rest of Europe Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.3.14.2 Rest of Europe Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.3.14.3 Rest of Europe Vascular Closure Devices Market Estimates and Forecasts, By End Use(2021-2032) (USD Billion)
10.4 Asia-Pacific
10.4.1 Trends Analysis
10.4.2 Asia-Pacific Vascular Closure Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.4.3 Asia-Pacific Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.4.4 Asia-Pacific Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.5 Asia-Pacific Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4.6 China
10.4.6.1 China Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.4.6.2 China Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.6.3 China Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4.7 India
10.4.7.1 India Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.4.7.2 India Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.7.3 India Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.4.8.2 Japan Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.8.3 Japan Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.4.9.2 South Korea Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.9.3 South Korea Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4.10 Singapore
10.4.10.1 Singapore Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.4.10.2 Singapore Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.10.3 Singapore Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4.11 Australia
10.4.11.1 Australia Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.4.11.2 Australia Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.11.3 Australia Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.4.12 Rest of Asia-Pacific
10.4.12.1 Rest of Asia-Pacific Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.4.12.2 Rest of Asia-Pacific Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.4.12.3 Rest of Asia-Pacific Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Trends Analysis
10.5.2 Middle East and Africa East Vascular Closure Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.5.3 Middle East and Africa Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.5.4 Middle East and Africa Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.5.5 Middle East and Africa Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.5.6 UAE
10.5.6.1 UAE Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.5.6.2 UAE Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.5.6.3 UAE Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.5.7 Saudi Arabia
10.5.7.1 Saudi Arabia Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.5.7.2 Saudi Arabia Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.5.7.3 Saudi Arabia Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.5.8 Qatar
10.5.8.1 Qatar Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.5.8.2 Qatar Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.5.8.3 Qatar Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.5.9 South Africa
10.5.9 1 South Africa Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.5.9 2 South Africa Vascular Closure Devices Market Estimates and Forecasts By Application (2021-2032) (USD Billion)
10.5.9 3 South Africa Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.5.10 Rest of Middle East & Africa
10.5.10.1 Rest of Middle East & Africa Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.5.10.2 Rest of Middle East & Africa Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.5.10.3 Rest of Middle East & Africa Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America Vascular Closure Devices Market Estimates and Forecasts, by Country (2021-2032) (USD Billion)
10.6.3 Latin America Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.6.4 Latin America Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.6.5 Latin America Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.6.6.2 Brazil Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.6.6.3 Brazil Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.6.7.2 Argentina Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.6.7.3 Argentina Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
10.6.8 Rest of Latin America
10.6.8.1 Rest of Latin America Vascular Closure Devices Market Estimates and Forecasts, by Product (2021-2032) (USD Billion)
10.6.8.2 Rest of Latin America Vascular Closure Devices Market Estimates and Forecasts, By Application (2021-2032) (USD Billion)
10.6.8.3 Rest of Latin America Vascular Closure Devices Market Estimates and Forecasts, By End Use (2021-2032) (USD Billion)
12. Company Profiles
12.1 Abbott
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.2 Medtronic
12.2.1 Company Overview
12.2.2 Financial
12.2.3 Products/ Services Offered
12.2.4 SWOT Analysis
12.3 Terumo Medical Corporation
12.3.1 Company Overview
12.3.2 Financial
12.3.3 Products/ Services Offered
12.3.4 SWOT Analysis
12.4 Cardinal Health
12.4.1 Company Overview
12.4.2 Financial
12.4.3 Products/ Services Offered
12.4.4 SWOT Analysis
12.5 Teleflex Incorporated
12.5.1 Company Overview
12.5.2 Financial
12.5.3 Products/ Services Offered
12.5.4 SWOT Analysis
12.6 Merit Medical Systems
12.6.1 Company Overview
12.6.2 Financial
12.6.3 Products/ Services Offered
12.6.4 SWOT Analysis
12.7 Haemonetics Corporation
12.7.1 Company Overview
12.7.2 Financial
12.7.3 Products/ Services Offered
12.7.4 SWOT Analysis
12.8 Boston Scientific Corporation
12.8.1 Company Overview
12.8.2 Financial
12.8.3 Products/ Services Offered
12.8.4 SWOT Analysis
12.9 Vivasure Medical
12.9.1 Company Overview
12.9.2 Financial
12.9.3 Products/ Services Offered
12.9.4 SWOT Analysis
12.10 Vasorum Ltd.
12.10.1 Company Overview
12.10.2 Financial
12.10.3 Products/ Services Offered
12.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Product
Passive Approximators
Collagen Pugs
Sealant or Gel-based Devices
Compression-assist Devices
Active Approximators
Suture-based Devices
Clip-based Devices
External Homeostatic Devices
By Application
Cardiac Interventions
Cerebrovascular Interventions
Peripheral Vascular Interventions
Others
By End Use
Hospitals and Clinics
Ambulatory Surgical Centers
Cardiac Catherization Laboratories
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Poland
Turkey
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
UAE
Saudi Arabia
Qatar
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g., Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players